[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-162084-105":53,"doc-detail-162084-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","chd-prevalence-model-technical-document-v11","CHD Prevalence Model - Technical Document v1.1","","Coronary heart disease (CHD) prevalence modeling for small populations, produced for Public Health England by authors from the Department of Primary Care & Public Health, School of Public Health. The technical document outlines background on cardiovascular disease risk factors, defines outcomes and risk-factor variables, and details statistical methods using UK survey data sources. It presents procedures for local prevalence estimation, internal and external validation, and summarizes results on CHD prevalence and regression modelling based on Whitehall II.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/chd-prevalence-model-technical-document-v11/162084/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/chd-prevalence-model-technical-document-v11/162084.png","ImageObject",442,249,{"name":88,"@type":89},"Maeve","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/vnd.openxmlformats-officedocument.wordprocessingml.document","2026-09-21","2026-08-30",true,{"@type":98,"interactionType":99,"userInteractionCount":79},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"What is the purpose of the CHD prevalence model for small populations?","Question",{"text":108,"@type":109},"To estimate coronary heart disease prevalence in small populations using UK survey and cohort data, supported by clearly defined outcomes and risk factors.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"Which data sources are used to discover inputs for the model?",{"text":113,"@type":109},"The document uses UK survey data sources including Whitehall II, Airwave Health Monitoring Study, Health Survey for England 2013, and the English Longitudinal Study of Ageing.",{"name":115,"@type":106,"acceptedAnswer":116},"How are local prevalence estimates produced and validated?",{"text":117,"@type":109},"Local prevalence estimation uses two methods—bootstrapping and logistic regression with inverse probability weights—followed by internal and external validation of the resulting estimates.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},162084,1788118104,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":79,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":135,"language":136,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":137,"faqs":138,"seo_title":139,"seo_description":61,"update_tm":125,"read_time":30},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","Coronary heart disease prevalence model for small populations:\nTechnical Document produced for Public Health England\nBenjamin Hollis, Roger Newson, Bowen Su, Sarah Onida, Alun Davies, Kosh Ray, Ioanna Tzoulaki & Michael Soljak\nDepartment of Primary Care & Public Health\nSchool of Public Health\n\u0003Contents\n\u0013 TOC \\o \"1-3\" \\h \\z \\u \u0014\u0013 HYPERLINK \\l \"_Toc456599769\" \u00141\tExecutive Summary\t\u0013 PAGEREF _Toc456599769 \\h \u00143\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599770\" \u00142\tBackground\t\u0013 PAGEREF _Toc456599770 \\h \u00144\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599771\" \u00142.1\tCVD Risk Factors\t\u0013 PAGEREF _Toc456599771 \\h \u00144\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599772\" \u00142.1.1\tEthnicity\t\u0013 PAGEREF _Toc456599772 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599773\" \u00142.1.2\tHypertension\t\u0013 PAGEREF _Toc456599773 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599774\" \u00142.1.3\tSmoking\t\u0013 PAGEREF _Toc456599774 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599775\" \u00142.1.4\tDiabetes\t\u0013 PAGEREF _Toc456599775 \\h \u00145\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599776\" \u00142.1.5\tObesity\t\u0013 PAGEREF _Toc456599776 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599777\" \u00142.1.6\tDyslipidaemia\t\u0013 PAGEREF _Toc456599777 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599778\" \u00142.1.7\tDeprivation and socioeconomic status\t\u0013 PAGEREF _Toc456599778 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599779\" \u00142.1.8\tPhysical Activity\t\u0013 PAGEREF _Toc456599779 \\h \u00146\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599780\" \u00142.1.9\tInflammatory Markers\t\u0013 PAGEREF _Toc456599780 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599781\" \u00142.1.10\tChronic Kidney Disease\t\u0013 PAGEREF _Toc456599781 \\h \u00147\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599782\" \u00142.2\tCHD incidence from literature\t\u0013 PAGEREF _Toc456599782 \\h \u00148\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599783\" \u00142.3\tCHD prevalence from the literature\t\u0013 PAGEREF _Toc456599783 \\h \u00149\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599784\" \u00143\tMethods\t\u0013 PAGEREF _Toc456599784 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599785\" \u00143.1\t“Data discovery” from UK survey data sources\t\u0013 PAGEREF _Toc456599785 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599786\" \u00143.1.1\tWhitehall II\t\u0013 PAGEREF _Toc456599786 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599787\" \u00143.1.2\tAirwave Health Monitoring Study\t\u0013 PAGEREF _Toc456599787 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599788\" \u00143.1.3\tHealth Survey for England 2013\t\u0013 PAGEREF _Toc456599788 \\h \u001411\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599789\" \u00143.1.4\tEnglish Longitudinal Study of Ageing\t\u0013 PAGEREF _Toc456599789 \\h \u001412\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599790\" \u00143.2\tOutcomes definitions\t\u0013 PAGEREF _Toc456599790 \\h \u001414\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599791\" \u00143.3\tRisk Factor Variables\t\u0013 PAGEREF _Toc456599791 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599792\" \u00143.3.1\tAge\t\u0013 PAGEREF _Toc456599792 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599793\" \u00143.3.2\tSex\t\u0013 PAGEREF _Toc456599793 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599794\" \u00143.3.3\tEthnicity\t\u0013 PAGEREF _Toc456599794 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599795\" \u00143.3.4\tHypertension\t\u0013 PAGEREF _Toc456599795 \\h \u001416\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599796\" \u00143.3.5\tDyslipidaemia\t\u0013 PAGEREF _Toc456599796 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599797\" \u00143.3.6\tFamily History (CHD)\t\u0013 PAGEREF _Toc456599797 \\h \u001417\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599798\" \u00143.3.7\tSmoking\t\u0013 PAGEREF _Toc456599798 \\h \u001418\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599799\" \u00143.3.8\tObesity\t\u0013 PAGEREF _Toc456599799 \\h \u001419\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599800\" \u00143.3.9\tDiabetes\t\u0013 PAGEREF _Toc456599800 \\h \u001419\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599801\" \u00143.3.10\tChronic Kidney Disease\t\u0013 PAGEREF _Toc456599801 \\h \u001419\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599802\" \u00143.3.11\t“Hypercoagulable state”/on anti-coagulant\t\u0013 PAGEREF _Toc456599802 \\h \u001419\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599803\" \u00143.3.12\tInflammatory Markers\t\u0013 PAGEREF _Toc456599803 \\h \u001420\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599804\" \u00143.3.13\tSocioeconomic status/deprivation\t\u0013 PAGEREF _Toc456599804 \\h \u001420\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599805\" \u00143.3.14\tPhysical Activity\t\u0013 PAGEREF _Toc456599805 \\h \u001420\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599806\" \u00143.4\tStatistical Analyses\t\u0013 PAGEREF _Toc456599806 \\h \u001421\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599807\" \u00143.4.1\tWhitehall II missing data\t\u0013 PAGEREF _Toc456599807 \\h \u001421\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599808\" \u00143.4.2\tWhitehall II descriptive analyses\t\u0013 PAGEREF _Toc456599808 \\h \u001421\u0015\u0015\n\u0013 HYPERLINK \\l \"_Toc456599809\" \u00143.4.3\tWhitehall II regression modelling\t\u0013 PA","cbCaig70slyylLOO","https://ap.wps.com/l/cbCaig70slyylLOO","docx",285065,45,"English","# Executive Summary\n# Background\n## CVD Risk Factors\n## CHD incidence from literature\n## CHD prevalence from the literature\n# Methods\n## Data discovery from UK survey data sources\n## Outcomes definitions\n## Risk Factor Variables\n## Statistical Analyses\n## Local prevalence estimates\n## Validation of local estimates\n# Results\n## Cardiovascular disease prevalence from Whitehall II Data\n## Whitehall II CHD definitions, incidence & prevalence\n## CHD regression modelling\n## Internal validation","[{\"question\":\"What is the purpose of the CHD prevalence model for small populations?\",\"answer\":\"To estimate coronary heart disease prevalence in small populations using UK survey and cohort data, supported by clearly defined outcomes and risk factors.\"},{\"question\":\"Which data sources are used to discover inputs for the model?\",\"answer\":\"The document uses UK survey data sources including Whitehall II, Airwave Health Monitoring Study, Health Survey for England 2013, and the English Longitudinal Study of Ageing.\"},{\"question\":\"How are local prevalence estimates produced and validated?\",\"answer\":\"Local prevalence estimation uses two methods—bootstrapping and logistic regression with inverse probability weights—followed by internal and external validation of the resulting estimates.\"}]","CHD Prevalence Model - Technical Document v1.1 | DOCX"]